1
Clinical Trials associated with Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke) / Enrolling by invitationPhase 1IIT A Phase 1 Clinical Trial of Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease
This research study is evaluating an investigational cell product called autologous induced pluripotent stem cell (iPSC)-derived dopamine neurons. This research study is a single-center Phase 1 clinical trial, which will test the safety of injecting the investigational cell product into the brain of subjects with Parkinson's disease.
100 Clinical Results associated with Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke)
100 Translational Medicine associated with Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke)
100 Patents (Medical) associated with Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke)
100 Deals associated with Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke)